Eric H. Bjerkholt's Insider Trades & SAST Disclosures
Eric H. Bjerkholt's most recent trade in Surrozen Inc was a trade of 1,333 Option (right to buy) done . Disclosure was reported to the exchange on May 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Eric H. Bjerkholt.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Surrozen Inc | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 1,333 | 1,333 | - | - | Option (right to buy) | |
| Metagenomi Inc. | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 42,000 | 42,000 | - | - | Stock Option (Right to Buy) | |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2025 | 2,667 | 35,946 (0%) | 0% | - | Common Stock | |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2025 | 2,667 | 5,333 | - | - | Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 10,000 | 10,000 | - | - | Restricted Stock Units | |
| Cerus Corp. | Eric H. Bjerkholt | Director | Sale of securities on an exchange or to another person at price $ 1.78 per share. | 12 Dec 2024 | 20,000 | 162,133 (0%) | 0% | 1.8 | 35,700 | Common Stock |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 21.05 per share. | 08 Nov 2024 | 475 | 33,279 (0%) | 0% | 21.0 | 9,997 | Common Stock |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 18,334 | 32,804 (0%) | 0% | - | Common Stock | |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 18,334 | 36,666 | - | - | Restricted Stock Units | |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2024 | 10,000 | 10,000 | - | - | Director Stock Option (Right to Buy) | |
| Cerus Corp. | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 5.00 per share. | 05 Jun 2024 | 40,000 | 182,133 (0%) | 0% | 5 | 200,000 | Common Stock |
| Surrozen Inc | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 1,333 | 1,333 | - | - | Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 21.05 per share. | 10 May 2024 | 470 | 14,470 (0%) | 0% | 21.0 | 9,892 | Common Stock |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 10,000 | 10,000 | - | - | Director Stock Option (Right to Buy) | |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 24.80 per share. | 27 Mar 2024 | 2,000 | 14,000 (0%) | 0% | 24.8 | 49,600 | Common Stock |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 25.80 per share. | 18 Mar 2024 | 2,000 | 12,000 (0%) | 0% | 25.8 | 51,600 | Common Stock |
| Mirum Pharmaceuticals Inc | H. Bjerkholt Eric | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 32,000 | 32,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 8,000 | 8,000 | - | - | Restricted Stock Units | |
| Cerus Corp. | H. Eric Bjerkholt | Director | Purchase of securities on an exchange or from another person at price $ 1.62 per share. | 13 Dec 2023 | 10,000 | 142,133 (0%) | 0% | 1.6 | 16,200 | Common Stock |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2023 | 110,000 | 110,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2023 | 55,000 | 55,000 | - | - | Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 29.65 per share. | 11 Sep 2023 | 10,000 | 10,000 (0%) | 0% | 29.6 | 296,492 | Common Stock |
| Cerus Corp. | Eric H. Bjerkholt | Director | Purchase of securities on an exchange or from another person at price $ 1.72 per share. | 21 Aug 2023 | 10,000 | 132,133 (0%) | 0% | 1.7 | 17,151 | Common Stock |
| Cerus Corp. | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 5.00 per share. | 07 Jun 2023 | 40,000 | 122,133 (0%) | 0% | 5 | 200,000 | Common Stock |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Purchase of securities on an exchange or from another person at price $ 4.20 per share. | 30 May 2023 | 150 | 3,684 | - | 4.2 | 630 | Common Stock |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Purchase of securities on an exchange or from another person at price $ 4.09 per share. | 30 May 2023 | 100 | 3,534 | - | 4.1 | 409 | Common Stock |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Purchase of securities on an exchange or from another person at price $ 3.20 per share. | 30 May 2023 | 5 | 3,434 | - | 3.2 | 16 | Common Stock |
| Cerus Corp. | Eric H. Bjerkholt | Director | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 23 May 2023 | 5,000 | 82,133 (0%) | 0% | 2 | 10,000 | Common Stock |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Purchase of securities on an exchange or from another person at price $ 3.27 per share. | 23 May 2023 | 500 | 3,429 | - | 3.3 | 1,634 | Common Stock |
| Surrozen Inc | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 20,000 | 20,000 | - | - | Option (right to buy) | |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Purchase of securities on an exchange or from another person at price $ 2.65 per share. | 18 May 2023 | 199 | 2,929 | - | 2.6 | 527 | Common Stock |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Purchase of securities on an exchange or from another person at price $ 3.00 per share. | 18 May 2023 | 1 | 2,730 | - | 3 | 3 | Common Stock |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Purchase of securities on an exchange or from another person at price $ 2.70 per share. | 16 May 2023 | 800 | 2,229 | - | 2.7 | 2,160 | Common Stock |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Purchase of securities on an exchange or from another person at price $ 2.70 per share. | 16 May 2023 | 300 | 2,729 | - | 2.7 | 810 | Common Stock |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Purchase of securities on an exchange or from another person at price $ 2.67 per share. | 16 May 2023 | 200 | 2,429 | - | 2.7 | 534 | Common Stock |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2023 | 20,000 | 20,000 | - | - | Director Stock Option (Right to Buy) | |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2023 | 1,429 | 1,429 | - | - | Common Stock | |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2023 | 1,429 | 0 | - | - | Restricted Stock Unit | |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 20,000 | 20,000 | - | - | Restricted Stock Units | |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Cerus Corp. | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 39,866 | 39,866 | - | - | Option (Right to Buy) | |
| Cerus Corp. | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 20,454 | 77,133 (0%) | 0% | 0 | Common Stock | |
| Cerus Corp. | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 29,983 | 29,983 | - | - | Option (Right to Buy) | |
| Cerus Corp. | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 14,888 | 56,679 (0%) | 0% | 0 | Common Stock | |
| Cerus Corp. | Eric H. Bjerkholt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 13,228 | 41,791 (0%) | 0% | - | Common Stock | |
| Cerus Corp. | Eric H. Bjerkholt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 13,228 | 0 | - | - | Restricted Stock Unit | |
| Cerus Corp. | Eric H. Bjerkholt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2020 | 4,281 | 28,563 (0%) | 0% | - | Common Stock | |
| Cerus Corp. | Eric H. Bjerkholt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2020 | 4,281 | 4,281 | - | - | Restricted Stock Unit | |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2020 | 25,000 | 25,000 | - | - | Director Stock Option (Right to Buy) | |
| Cerus Corp. | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2020 | 28,177 | 28,177 | - | - | Option (Right to Buy) | |
| Cerus Corp. | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2020 | 13,228 | 13,228 | - | - | Restricted Stock Unit |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges